ProCE Banner Activity

Key Studies Influencing My Practice Following EACS 2021

Slideset Download
Conference Coverage
Read expert faculty members’ summaries of key studies from EACS 2021, including results from studies on BIC/FTC/TAF in a test-and-treat model; islatravir and doravirine in treatment naïve patients; DTG/3TC in patients with an M184V mutation; long-acting CAB + RPV by BMI category, patient satisfaction, and outcomes after discontinuation; lenacapavir in heavily treatment experienced patients; and COVID-19 vaccine effectiveness and the impact of the pandemic on virologic suppression in PWH.

Released: November 15, 2021

Expiration: November 14, 2022

No longer available for credit.
Begin Activity

Share

Faculty

Tristan J. Barber

Tristan J. Barber, MA, MD, FRCP

Honorary Associate Professor
Institute for Global Health
University College London
Consultant in HIV Medicine
Ian Charleson Day Centre
Royal Free Hospital
London, United Kingdom

Chloe Orkin

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities
Faculty of Medicine and Dentistry
Queen Mary University of London
London, United Kingdom

Jürgen K. Rockstroh

Jürgen K. Rockstroh, MD

Head of Infectious Diseases
Professor of Medicine 
University Hospital Bonn
Bonn, Germany  

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Gilead Sciences, Inc.

Merck Sharp & Dohme Corp.

ViiV Healthcare

Faculty Disclosure

Primary Author

Tristan J. Barber, MA, MD, FRCP

Honorary Associate Professor
Institute for Global Health
University College London
Consultant in HIV Medicine
Ian Charleson Day Centre
Royal Free Hospital
London, United Kingdom

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities
Faculty of Medicine and Dentistry
Queen Mary University of London
London, United Kingdom

Jürgen K. Rockstroh, MD

Head of Infectious Diseases
Professor of Medicine 
University Hospital Bonn
Bonn, Germany